MiMedx Group Inc (MDXG)
7.455
+0.22
(+2.97%)
USD |
NASDAQ |
May 10, 16:00
7.455
0.00 (0.00%)
After-Hours: 20:00
MiMedx Group Free Cash Flow (Quarterly): -0.166M for March 31, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -0.166M |
| December 31, 2023 | 9.83M |
| September 30, 2023 | 12.16M |
| June 30, 2023 | 7.476M |
| March 31, 2023 | -4.681M |
| December 31, 2022 | -7.291M |
| September 30, 2022 | 0.61M |
| June 30, 2022 | -3.385M |
| March 31, 2022 | -10.34M |
| December 31, 2021 | -3.557M |
| September 30, 2021 | 5.783M |
| June 30, 2021 | 1.194M |
| March 31, 2021 | -8.62M |
| December 31, 2020 | -12.42M |
| September 30, 2020 | -5.27M |
| June 30, 2020 | -3.507M |
| March 31, 2020 | -13.29M |
| December 31, 2019 | -23.82M |
| September 30, 2019 | -3.316M |
| June 30, 2019 | 1.879M |
| March 31, 2019 | -15.91M |
| December 31, 2018 | -0.295M |
| September 30, 2018 | 1.348M |
| June 30, 2018 | 18.22M |
| March 31, 2018 | 7.107M |
| Date | Value |
|---|---|
| December 31, 2017 | 19.74M |
| September 30, 2017 | 16.65M |
| June 30, 2017 | 11.71M |
| March 31, 2017 | 9.717M |
| December 31, 2016 | 13.80M |
| September 30, 2016 | 1.299M |
| June 30, 2016 | 5.533M |
| March 31, 2016 | -2.985M |
| December 31, 2015 | 2.705M |
| September 30, 2015 | 5.645M |
| June 30, 2015 | 1.767M |
| March 31, 2015 | 2.863M |
| December 31, 2014 | 7.558M |
| September 30, 2014 | 8.263M |
| June 30, 2014 | 0.501M |
| March 31, 2014 | -2.078M |
| December 31, 2013 | 0.5121M |
| September 30, 2013 | 0.7734M |
| June 30, 2013 | -1.735M |
| March 31, 2013 | -2.172M |
| December 31, 2012 | -1.106M |
| September 30, 2012 | -1.026M |
| June 30, 2012 | -0.5026M |
| March 31, 2012 | -1.335M |
| December 31, 2011 | -1.724M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-23.82M
Minimum
Dec 2019
12.16M
Maximum
Sep 2023
-3.037M
Average
-3.446M
Median
Free Cash Flow (Quarterly) Benchmarks
| TELA Bio Inc | -11.26M |
| Amylyx Pharmaceuticals Inc | 13.20M |
| CEL-SCI Corp | -4.953M |
| AIM ImmunoTech Inc | -9.956M |
| IGC Pharma Inc | -1.674M |